Hospital Acquired Infection Control Market By Offering (Equipment (Sterilization & Monitoring (Steam Sterilizers, Low Temperature Sterilizers, Ethylene Oxide (EO) Sterilizers, Biological Indicators, & Others), Washer Disinfectors, Endoscope Reprocessor Systems, and Others), Consumables (Personal Protective Equipment (PPE), Disinfectants, and Others), and Services (Training & Education, Support Services, & Others)); By End Users (Hospitals & Intensive Care Units (ICUs), Ambulatory Surgical Centers & Diagnostic Centers, and Others); By Distribution Channels (Direct and Indirect); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Hospital acquired infections (HAI) are also known as healthcare associated infections and nosocomial infections. These infections are acquired infections which are usually not present or incubating at the time of a patient being admitted to a hospital. These infections include bloodstream infections, catheter-associated urinary tract infections, central line-associated surgical site infections, clostridium difficile, infections hospital-acquired pneumonia, and ventilator-associated pneumonia. Symptoms indicating an infection include abdominal pain, altered mental status, costovertebral angle tenderness, dysuria, palpitations, polyuria, productive cough, rebound tenderness, shortness of breath, and suprapubic pain. The market for medical devices and chemical solutions meant to prevent HAI is thus gaining traction amidst the coronavirus pandemic.
The increasing prevalence of medical device disinfection due to coronavirus pandemic is driving the growth of global hospital acquired infection control market. Other factors contributing to the market growth include growth in medical expenditure, large patient pool, government support to the development of medical infrastructure, high incidence of hospital-acquired infections, increasing adoption rate of sophisticated medical devices, technological advancements in sterilization equipment, the increasing number of surgical procedures, innovations focused on avoiding cross contaminations, higher emphasis on patient's safety in developed countries, growing awareness of environmental as well as personal hygiene due to COVID-19, increasing incidence of chronic diseases, and high demand for devices such as endoscope reprocessing devices.
Equipment sterilization significantly prevents the spread of COVID-19 in healthcare settings as patient-to-patient pathogen transmission via medical devices can be prevented if medical devices are properly sterilized. During the pandemic, using reprocessed equipment to disinfect or sterilize medical devices is higher than normal because improper decontamination of surgical instruments, respiratory care devices, endoscopic devices, and reusable hemodialysis machines can increase the risk of COVID-19. Hence, coronavirus outbreak has certainly increased the demand for sterilization so that the proper sterilization of medical devices can be ensured. Due to COVID-19, not only the demand for sterilization is increasing but governments and many private companies are taking various initiatives to increase the sterilization capacity of medical devices. As most COVID patients go to hospital in order to receive medical care, the chances for many visitors to get exposed to coronavirus HAI remain high. In 2020, the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report detailed an increase in HAI Carbapenem-Resistant Acinetobacter baumannii (CRAB) in a New Jersey acute care hospital during a COVID-19 surge. The report highlighted that this surge happened due to reduced attention to the implementation of infection control and prevention (IPC) measures which included hand hygiene compliance. Hence, stringent measures undertaken by institutions globally towards efficient hygiene and sterilization procedures is contributing towards the growth of global hospital acquired infection control market.
The increasing use of E-beam sterilization, growing healthcare industry, reintroduction of ethylene oxide sterilization, and outsourcing of surgical operation to emerging countries is anticipated to showcase substantial opportunities for the global hospital acquired infection control market over the forecast period. In August 2020, Sotera Health acquired Canadian-based Iotron Industries. Iotron Industries is engaged in the provision of electron beam (EBeam), which is used for the sterilization of medical devices. This acquisition is not only set to expand the Sotera Health's electron beam (EBeam) footprint, but to also add new expertise to its business of Sterigenics.
In terms of revenue, hospital acquired infection control market was valued at US$ 23.24 Bn in 2020 growing at a CAGR of 4% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Hospital Acquired Infection Control Market Revenue & Forecast, (US$ Million), 2015 – 2029
Offering Outlook:
In the context of offering, the global hospital acquired infection control market has been primarily segmented into equipment, consumables, and services. The equipment segment has been sub-segmented into sterilization & monitoring, washer disinfectors, endoscope reprocessor systems, and others. The sterilization & monitoring category has been further classified into low temperature sterilizers, ethylene oxide (EO) sterilizers, biological indicators, and others. The consumables segment has been further segmented into personal protective equipment (PPE), disinfectants, and others. The services segment has been further segmented into training & education, support services, and others.
The equipment segment accounted for the largest market share in 2020 due to high demand for products covered in this segment. Steam sterilizers are safe, reliable, efficient and easy to use. They are eco-friendly and kill germs, viruses, and molds. They can also destroy allergens and eliminate odors. Fully stainless steel construction of these sterilizers allows for clean steam use without any kind of costly upgrades. In May 2021, Tom Tippee super-steam advanced electric sterilizer was introduced in the market. It has been designed to eliminate harmful bacteria that can build up in milk bottles for babies and other feeding accessories.
Low-temperature sterilization technologies are used for sterilizing surgical equipment and supplies that are heat-sensitive or moisture-intolerant. It is a preferred sterilization solution for heat & moisture sensitive equipment in central sterile supply departments (CSSDs) and gastroenterology & respiratory endoscopy clinics. In November 2019, a subsidiary of Stryker Corporation acquired, TSO3 which is an innovator in low-temperature sterilization technology that is useful for medical devices. The consumables segment is expected to achieve tremendous growth in global hospital acquired infection control market during the forecast period (2021 – 2029).
End Users Outlook:
Regarding end users, the global hospital acquired infection control market has been primarily segmented into hospitals & intensive care units (ICUs), ambulatory surgical centers & diagnostic centers, and others. The hospitals & intensive care units (ICUs) category accounted for the largest market share in 2020. The ambulatory surgical centers (ASC) & diagnostic centers category is expected to achieve tremendous growth in global hospital acquired infection control market during the forecast period due to the rising prevalence of HAIs, growing medical devices industry, increasing adoption of single-use medical devices, and rising number of surgical procedures all over the world. Other factors contributing to the market growth include increasing demand for minimally invasive surgeries, increased public health awareness, increasing number of outpatients, initiatives by the government to provide ambulatory surgical services, and growth in the development of outpatient services.
Region Outlook:
North America accounted for a significant share in the global hospital acquired infection control market in 2020. However, during the forecast period, Asia Pacific region is expected to become the fastest growing regional market. Favorable government regulations in countries like Japan, South Korea and Singapore are contributing to the market growth. Large patient population in emerging economies like China and India, increasing demand for endoscope reprocessing devices and many other disinfecting medical devices is also boosting the market growth. Other major factors contributing to the market growth in this region include the rising number of surgical procedures conducted annually, rising incidence of COVID-19, economic development in emerging economies, government support for healthcare infrastructure development, rising medical expenditure and increasing installation as well as usage of sophisticated medical devices such as endoscopes in medical institutions like hospitals.
Competitive Landscape Outlook:
The report provides both, qualitative as well as quantitative research of global hospital acquired infection control market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some key players in the global hospital acquired infection control market are 3M, ASP, BELIMED INC., ContecClean, Drägerwerk AG & Co. KGaA, Ecolab Inc., Getinge AB, Keystone Healthcare, MATACHANA GROUP, MELAG Medizintechnik GmbH & Co. KG, Sterigenics U.S. LLC, and STERIS amongst other market participants.
Global Hospital Acquired Infection Control Market:
By Offering
- Equipment
- Sterilization & Monitoring
- Steam Sterilizers
- Low Temperature Sterilizers
- Ethylene Oxide (EO) Sterilizers
- Biological Indicators
- Others
- Washer Disinfectors
- Endoscope Reprocessor Systems
- Others
- Sterilization & Monitoring
- Consumables
- Personal Protective Equipment (PPE)
- Disinfectants
- Others
- Services
- Training & Education
- Support Services
- Others
By End Users
- Hospitals & Intensive Care Units (ICUs)
- Ambulatory Surgical Centers & Diagnostic Centers
- Others
By Distribution Channels
- Direct
- Indirect
By Region
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Hospital Acquired Infection Control
Market
6. Market Synopsis:
Hospital Acquired Infection Control Market
7. Hospital Acquired Infection Control Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Hospital Acquired Infection Control Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Hospital Acquired Infection Control Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Hospital Acquired Infection Control Market
8. Global Hospital Acquired Infection Control Market Analysis
and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Hospital Acquired Infection Control Market Revenue (US$ Mn)
8.2. Global
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
Offering
8.2.1. Equipment
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Sterilization & Monitoring,
Washer Disinfectors, Endoscope Reprocessor Systems, Others)
8.2.1.1. Sterilization & Monitoring
8.2.1.1.1. Steam Sterilizers
8.2.1.1.2. Low Temperature Sterilizers
8.2.1.1.3. Ethylene Oxide (EO) Sterilizers
8.2.1.1.4. Biological Indicators
8.2.1.1.5. Others
8.2.1.2. Washer Disinfectors
8.2.1.3. Endoscope Reprocessor Systems
8.2.1.4. Others
8.2.2. Consumables
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Personal Protective Equipment
(PPE), Disinfectants, Others)
8.2.2.1. Personal Protective Equipment (PPE)
8.2.2.2. Disinfectants
8.2.2.3. Others
8.2.3. Services
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Training & Education, Support
Services, Others)
8.2.3.1. Training & Education
8.2.3.2. Support Services
8.2.3.3. Others
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Hospital Acquired Infection Control Market Analysis
and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
End Users
9.2.1. Hospitals
& Intensive Care Units (ICUs)
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 - 2020
9.2.1.5.1.2. Market Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2020
9.2.1.5.2.2. Market Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2020
9.2.1.5.3.2. Market Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2020
9.2.1.5.4.2. Market Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 - 2020
9.2.1.5.5.2. Market Forecast, 2021 - 2029
9.2.2. Ambulatory
Surgical Centers & Diagnostic Centers
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market Estimation, 2015 - 2020
9.2.2.5.1.2. Market Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2020
9.2.2.5.2.2. Market Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2020
9.2.2.5.3.2. Market Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2020
9.2.2.5.4.2. Market Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market Estimation, 2015 - 2020
9.2.2.5.5.2. Market Forecast, 2021 - 2029
9.2.3. Others
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market Estimation, 2015 - 2020
9.2.3.5.1.2. Market Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2020
9.2.3.5.2.2. Market Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2020
9.2.3.5.3.2. Market Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2020
9.2.3.5.4.2. Market Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market Estimation, 2015 - 2020
9.2.3.5.5.2. Market Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By End
Users
10. Global Hospital Acquired Infection Control Market Analysis
and Forecasts, 2021 – 2029
10.1. Overview
10.2. Global
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
10.2.1. Direct
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1.
Market Estimation, 2015 - 2020
10.2.1.5.1.2.
Market Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1.
Market Estimation, 2015 - 2020
10.2.1.5.2.2.
Market Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1.
Market Estimation, 2015 - 2020
10.2.1.5.3.2.
Market Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1.
Market Estimation, 2015 - 2020
10.2.1.5.4.2.
Market Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1.
Market Estimation, 2015 - 2020
10.2.1.5.5.2.
Market Forecast, 2021 - 2029
10.2.2. Indirect
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1.
Market Estimation, 2015 - 2020
10.2.2.5.1.2.
Market Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1.
Market Estimation, 2015 - 2020
10.2.2.5.2.2.
Market Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1.
Market Estimation, 2015 - 2020
10.2.2.5.3.2.
Market Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1.
Market Estimation, 2015 - 2020
10.2.2.5.4.2.
Market Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1.
Market Estimation, 2015 - 2020
10.2.2.5.5.2.
Market Forecast, 2021 - 2029
10.3. Key Segment
for Channeling Investments
10.3.1. By
Distribution Channel
11. North America Hospital Acquired Infection Control Market
Analysis and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North
America Hospital Acquired Infection Control Market Revenue (US$ Mn)
11.2. North
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Offering
11.2.1. Equipment
11.2.1.1. Sterilization & Monitoring
11.2.1.1.1. Steam Sterilizers
11.2.1.1.2. Low Temperature Sterilizers
11.2.1.1.3. Ethylene Oxide (EO) Sterilizers
11.2.1.1.4. Biological Indicators
11.2.1.1.5. Others
11.2.1.2. Washer Disinfectors
11.2.1.3. Endoscope Reprocessor Systems
11.2.1.4. Others
11.2.2. Consumables
11.2.2.1. Personal Protective Equipment (PPE)
11.2.2.2. Disinfectants
11.2.2.3. Others
11.2.3. Services
11.2.3.1. Training & Education
11.2.3.2. Support Services
11.2.3.3. Others
11.3. North
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By End Users
11.3.1. Hospitals
& Intensive Care Units (ICUs)
11.3.2. Ambulatory
Surgical Centers & Diagnostic Centers
11.3.3. Others
11.4. North
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
11.4.1. Direct
11.4.2. Indirect
11.5. North
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
11.5.1.1.1. Equipment
11.5.1.1.1.1.
Sterilization & Monitoring
11.5.1.1.1.1.1. Steam Sterilizers
11.5.1.1.1.1.2. Low Temperature Sterilizers
11.5.1.1.1.1.3. Ethylene Oxide (EO) Sterilizers
11.5.1.1.1.1.4. Biological Indicators
11.5.1.1.1.1.5. Others
11.5.1.1.1.2.
Washer Disinfectors
11.5.1.1.1.3.
Endoscope Reprocessor Systems
11.5.1.1.1.4.
Others
11.5.1.1.2. Consumables
11.5.1.1.2.1.
Personal Protective Equipment
(PPE)
11.5.1.1.2.2.
Disinfectants
11.5.1.1.2.3.
Others
11.5.1.1.3. Services
11.5.1.1.3.1.
Training & Education
11.5.1.1.3.2.
Support Services
11.5.1.1.3.3.
Others
11.5.1.2. U.S Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
11.5.1.2.1. Hospitals & Intensive Care Units (ICUs)
11.5.1.2.2. Ambulatory Surgical Centers & Diagnostic Centers
11.5.1.2.3. Others
11.5.1.3. U.S Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
11.5.1.3.1. Direct
11.5.1.3.2. Indirect
11.5.2. Canada
11.5.2.1. Canada Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
11.5.2.1.1. Equipment
11.5.2.1.1.1.
Sterilization & Monitoring
11.5.2.1.1.1.1. Steam Sterilizers
11.5.2.1.1.1.2. Low Temperature Sterilizers
11.5.2.1.1.1.3. Ethylene Oxide (EO) Sterilizers
11.5.2.1.1.1.4. Biological Indicators
11.5.2.1.1.1.5. Others
11.5.2.1.1.2.
Washer Disinfectors
11.5.2.1.1.3.
Endoscope Reprocessor Systems
11.5.2.1.1.4.
Others
11.5.2.1.2. Consumables
11.5.2.1.2.1.
Personal Protective Equipment
(PPE)
11.5.2.1.2.2.
Disinfectants
11.5.2.1.2.3.
Others
11.5.2.1.3. Services
11.5.2.1.3.1.
Training & Education
11.5.2.1.3.2.
Support Services
11.5.2.1.3.3.
Others
11.5.2.2. Canada Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
11.5.2.2.1. Hospitals & Intensive Care Units (ICUs)
11.5.2.2.2. Ambulatory Surgical Centers & Diagnostic Centers
11.5.2.2.3. Others
11.5.2.3. Canada Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
11.5.2.3.1. Direct
11.5.2.3.2. Indirect
11.5.3. Mexico
11.5.3.1. Mexico Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
11.5.3.1.1. Equipment
11.5.3.1.1.1.
Sterilization & Monitoring
11.5.3.1.1.1.1. Steam Sterilizers
11.5.3.1.1.1.2. Low Temperature Sterilizers
11.5.3.1.1.1.3. Ethylene Oxide (EO) Sterilizers
11.5.3.1.1.1.4. Biological Indicators
11.5.3.1.1.1.5. Others
11.5.3.1.1.2.
Washer Disinfectors
11.5.3.1.1.3.
Endoscope Reprocessor Systems
11.5.3.1.1.4.
Others
11.5.3.1.2. Consumables
11.5.3.1.2.1.
Personal Protective Equipment
(PPE)
11.5.3.1.2.2.
Disinfectants
11.5.3.1.2.3.
Others
11.5.3.1.3. Services
11.5.3.1.3.1.
Training & Education
11.5.3.1.3.2.
Support Services
11.5.3.1.3.3.
Others
11.5.3.2. Mexico Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
11.5.3.2.1. Hospitals & Intensive Care Units (ICUs)
11.5.3.2.2. Ambulatory Surgical Centers & Diagnostic Centers
11.5.3.2.3. Others
11.5.3.3. Mexico Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
11.5.3.3.1. Direct
11.5.3.3.2. Indirect
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.4.1.1. Equipment
11.5.4.1.1.1.
Sterilization & Monitoring
11.5.4.1.1.1.1. Steam Sterilizers
11.5.4.1.1.1.2. Low Temperature Sterilizers
11.5.4.1.1.1.3. Ethylene Oxide (EO) Sterilizers
11.5.4.1.1.1.4. Biological Indicators
11.5.4.1.1.1.5. Others
11.5.4.1.1.2.
Washer Disinfectors
11.5.4.1.1.3.
Endoscope Reprocessor Systems
11.5.4.1.1.4.
Others
11.5.4.1.2. Consumables
11.5.4.1.2.1.
Personal Protective Equipment
(PPE)
11.5.4.1.2.2.
Disinfectants
11.5.4.1.2.3.
Others
11.5.4.1.3. Services
11.5.4.1.3.1.
Training & Education
11.5.4.1.3.2.
Support Services
11.5.4.1.3.3.
Others
11.5.4.2. Rest of North America Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.4.2.1. Hospitals & Intensive Care Units (ICUs)
11.5.4.2.2. Ambulatory Surgical Centers & Diagnostic Centers
11.5.4.2.3. Others
11.5.4.3. Rest of North America Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.5.4.3.1. Direct
11.5.4.3.2. Indirect
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Offering
11.6.3. By End
Users
11.6.4. By
Distribution Channel
12. Europe Hospital Acquired Infection Control Market Analysis
and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Europe
Hospital Acquired Infection Control Market Revenue (US$ Mn)
12.2. Europe
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
Offering
12.2.1. Equipment
12.2.1.1. Sterilization & Monitoring
12.2.1.1.1. Steam Sterilizers
12.2.1.1.2. Low Temperature Sterilizers
12.2.1.1.3. Ethylene Oxide (EO) Sterilizers
12.2.1.1.4. Biological Indicators
12.2.1.1.5. Others
12.2.1.2. Washer Disinfectors
12.2.1.3. Endoscope Reprocessor Systems
12.2.1.4. Others
12.2.2. Consumables
12.2.2.1. Personal Protective Equipment (PPE)
12.2.2.2. Disinfectants
12.2.2.3. Others
12.2.3. Services
12.2.3.1. Training & Education
12.2.3.2. Support Services
12.2.3.3. Others
12.3. Europe
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
End Users
12.3.1. Hospitals
& Intensive Care Units (ICUs)
12.3.2. Ambulatory
Surgical Centers & Diagnostic Centers
12.3.3. Others
12.4. Europe
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
12.4.1. Direct
12.4.2. Indirect
12.5. Europe
Hospital Acquired Infection Control Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.1. France
12.5.1.1. France Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.1.1.1. Equipment
12.5.1.1.1.1.
Sterilization & Monitoring
12.5.1.1.1.1.1. Steam Sterilizers
12.5.1.1.1.1.2. Low Temperature Sterilizers
12.5.1.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.1.1.1.1.4. Biological Indicators
12.5.1.1.1.1.5. Others
12.5.1.1.1.2.
Washer Disinfectors
12.5.1.1.1.3.
Endoscope Reprocessor Systems
12.5.1.1.1.4.
Others
12.5.1.1.2. Consumables
12.5.1.1.2.1.
Personal Protective Equipment
(PPE)
12.5.1.1.2.2.
Disinfectants
12.5.1.1.2.3.
Others
12.5.1.1.3. Services
12.5.1.1.3.1.
Training & Education
12.5.1.1.3.2.
Support Services
12.5.1.1.3.3.
Others
12.5.1.2. France Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.1.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.1.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.1.2.3. Others
12.5.1.3. France Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
12.5.1.3.1. Direct
12.5.1.3.2. Indirect
12.5.2. The UK
12.5.2.1. The UK Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.2.1.1. Equipment
12.5.2.1.1.1.
Sterilization & Monitoring
12.5.2.1.1.1.1. Steam Sterilizers
12.5.2.1.1.1.2. Low Temperature Sterilizers
12.5.2.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.2.1.1.1.4. Biological Indicators
12.5.2.1.1.1.5. Others
12.5.2.1.1.2.
Washer Disinfectors
12.5.2.1.1.3.
Endoscope Reprocessor Systems
12.5.2.1.1.4.
Others
12.5.2.1.2. Consumables
12.5.2.1.2.1.
Personal Protective Equipment
(PPE)
12.5.2.1.2.2.
Disinfectants
12.5.2.1.2.3.
Others
12.5.2.1.3. Services
12.5.2.1.3.1.
Training & Education
12.5.2.1.3.2.
Support Services
12.5.2.1.3.3.
Others
12.5.2.2. The UK Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.2.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.2.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.2.2.3. Others
12.5.2.3. The UK Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
12.5.2.3.1. Direct
12.5.2.3.2. Indirect
12.5.3. Spain
12.5.3.1. Spain Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.3.1.1. Equipment
12.5.3.1.1.1.
Sterilization & Monitoring
12.5.3.1.1.1.1. Steam Sterilizers
12.5.3.1.1.1.2. Low Temperature Sterilizers
12.5.3.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.3.1.1.1.4. Biological Indicators
12.5.3.1.1.1.5. Others
12.5.3.1.1.2.
Washer Disinfectors
12.5.3.1.1.3.
Endoscope Reprocessor Systems
12.5.3.1.1.4.
Others
12.5.3.1.2. Consumables
12.5.3.1.2.1.
Personal Protective Equipment
(PPE)
12.5.3.1.2.2.
Disinfectants
12.5.3.1.2.3.
Others
12.5.3.1.3. Services
12.5.3.1.3.1.
Training & Education
12.5.3.1.3.2.
Support Services
12.5.3.1.3.3.
Others
12.5.3.2. Spain Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.3.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.3.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.3.2.3. Others
12.5.3.3. Spain Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
12.5.3.3.1. Direct
12.5.3.3.2. Indirect
12.5.4. Germany
12.5.4.1. Germany Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Offering
12.5.4.1.1. Equipment
12.5.4.1.1.1.
Sterilization & Monitoring
12.5.4.1.1.1.1. Steam Sterilizers
12.5.4.1.1.1.2. Low Temperature Sterilizers
12.5.4.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.4.1.1.1.4. Biological Indicators
12.5.4.1.1.1.5. Others
12.5.4.1.1.2.
Washer Disinfectors
12.5.4.1.1.3.
Endoscope Reprocessor Systems
12.5.4.1.1.4.
Others
12.5.4.1.2. Consumables
12.5.4.1.2.1.
Personal Protective Equipment
(PPE)
12.5.4.1.2.2.
Disinfectants
12.5.4.1.2.3.
Others
12.5.4.1.3. Services
12.5.4.1.3.1.
Training & Education
12.5.4.1.3.2.
Support Services
12.5.4.1.3.3.
Others
12.5.4.2. Germany Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By End Users
12.5.4.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.4.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.4.2.3. Others
12.5.4.3. Germany Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
12.5.4.3.1. Direct
12.5.4.3.2. Indirect
12.5.5. Italy
12.5.5.1. Italy Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.5.1.1. Equipment
12.5.5.1.1.1.
Sterilization & Monitoring
12.5.5.1.1.1.1. Steam Sterilizers
12.5.5.1.1.1.2. Low Temperature Sterilizers
12.5.5.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.5.1.1.1.4. Biological Indicators
12.5.5.1.1.1.5. Others
12.5.5.1.1.2.
Washer Disinfectors
12.5.5.1.1.3.
Endoscope Reprocessor Systems
12.5.5.1.1.4.
Others
12.5.5.1.2. Consumables
12.5.5.1.2.1.
Personal Protective Equipment
(PPE)
12.5.5.1.2.2.
Disinfectants
12.5.5.1.2.3.
Others
12.5.5.1.3. Services
12.5.5.1.3.1.
Training & Education
12.5.5.1.3.2.
Support Services
12.5.5.1.3.3.
Others
12.5.5.2. Italy Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.5.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.5.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.5.2.3. Others
12.5.5.3. Italy Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
12.5.5.3.1. Direct
12.5.5.3.2. Indirect
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Offering
12.5.6.1.1. Equipment
12.5.6.1.1.1.
Sterilization & Monitoring
12.5.6.1.1.1.1. Steam Sterilizers
12.5.6.1.1.1.2. Low Temperature Sterilizers
12.5.6.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.6.1.1.1.4. Biological Indicators
12.5.6.1.1.1.5. Others
12.5.6.1.1.2.
Washer Disinfectors
12.5.6.1.1.3.
Endoscope Reprocessor Systems
12.5.6.1.1.4.
Others
12.5.6.1.2. Consumables
12.5.6.1.2.1.
Personal Protective Equipment
(PPE)
12.5.6.1.2.2.
Disinfectants
12.5.6.1.2.3.
Others
12.5.6.1.3. Services
12.5.6.1.3.1.
Training & Education
12.5.6.1.3.2.
Support Services
12.5.6.1.3.3.
Others
12.5.6.2. Nordic Countries Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.6.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.6.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.6.2.3. Others
12.5.6.3. Nordic Countries Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.6.3.1. Direct
12.5.6.3.2. Indirect
12.5.6.4. Nordic Countries Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Offering
12.5.7.1.1. Equipment
12.5.7.1.1.1.
Sterilization & Monitoring
12.5.7.1.1.1.1. Steam Sterilizers
12.5.7.1.1.1.2. Low Temperature Sterilizers
12.5.7.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.7.1.1.1.4. Biological Indicators
12.5.7.1.1.1.5. Others
12.5.7.1.1.2.
Washer Disinfectors
12.5.7.1.1.3.
Endoscope Reprocessor Systems
12.5.7.1.1.4.
Others
12.5.7.1.2. Consumables
12.5.7.1.2.1.
Personal Protective Equipment
(PPE)
12.5.7.1.2.2.
Disinfectants
12.5.7.1.2.3.
Others
12.5.7.1.3. Services
12.5.7.1.3.1.
Training & Education
12.5.7.1.3.2.
Support Services
12.5.7.1.3.3.
Others
12.5.7.2. Benelux Union Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.7.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.7.2.3. Others
12.5.7.3. Benelux Union Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.7.3.1. Direct
12.5.7.3.2. Indirect
12.5.7.4. Benelux Union Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Offering
12.5.8.1.1. Equipment
12.5.8.1.1.1.
Sterilization & Monitoring
12.5.8.1.1.1.1. Steam Sterilizers
12.5.8.1.1.1.2. Low Temperature Sterilizers
12.5.8.1.1.1.3. Ethylene Oxide (EO) Sterilizers
12.5.8.1.1.1.4. Biological Indicators
12.5.8.1.1.1.5. Others
12.5.8.1.1.2.
Washer Disinfectors
12.5.8.1.1.3.
Endoscope Reprocessor Systems
12.5.8.1.1.4.
Others
12.5.8.1.2. Consumables
12.5.8.1.2.1.
Personal Protective Equipment
(PPE)
12.5.8.1.2.2.
Disinfectants
12.5.8.1.2.3.
Others
12.5.8.1.3. Services
12.5.8.1.3.1.
Training & Education
12.5.8.1.3.2.
Support Services
12.5.8.1.3.3.
Others
12.5.8.2. Rest of Europe Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.2.1. Hospitals & Intensive Care Units (ICUs)
12.5.8.2.2. Ambulatory Surgical Centers & Diagnostic Centers
12.5.8.2.3. Others
12.5.8.3. Rest of Europe Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.5.8.3.1. Direct
12.5.8.3.2. Indirect
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Offering
12.6.3. By End
Users
12.6.4. By
Distribution Channel
13. Asia Pacific Hospital Acquired Infection Control Market
Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia
Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn)
13.2. Asia
Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Offering
13.2.1. Equipment
13.2.1.1. Sterilization & Monitoring
13.2.1.1.1. Steam Sterilizers
13.2.1.1.2. Low Temperature Sterilizers
13.2.1.1.3. Ethylene Oxide (EO) Sterilizers
13.2.1.1.4. Biological Indicators
13.2.1.1.5. Others
13.2.1.2. Washer Disinfectors
13.2.1.3. Endoscope Reprocessor Systems
13.2.1.4. Others
13.2.2. Consumables
13.2.2.1. Personal Protective Equipment (PPE)
13.2.2.2. Disinfectants
13.2.2.3. Others
13.2.3. Services
13.2.3.1. Training & Education
13.2.3.2. Support Services
13.2.3.3. Others
13.3. Asia
Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By End Users
13.3.1. Hospitals
& Intensive Care Units (ICUs)
13.3.2. Ambulatory
Surgical Centers & Diagnostic Centers
13.3.3. Others
13.4. Asia
Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.4.1. Direct
13.4.2. Indirect
13.5. Asia
Pacific Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Country
13.5.1. China
13.5.1.1. China Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
13.5.1.1.1. Equipment
13.5.1.1.1.1.
Sterilization & Monitoring
13.5.1.1.1.1.1. Steam Sterilizers
13.5.1.1.1.1.2. Low Temperature Sterilizers
13.5.1.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.1.1.1.1.4. Biological Indicators
13.5.1.1.1.1.5. Others
13.5.1.1.1.2.
Washer Disinfectors
13.5.1.1.1.3.
Endoscope Reprocessor Systems
13.5.1.1.1.4.
Others
13.5.1.1.2. Consumables
13.5.1.1.2.1.
Personal Protective Equipment
(PPE)
13.5.1.1.2.2.
Disinfectants
13.5.1.1.2.3.
Others
13.5.1.1.3. Services
13.5.1.1.3.1.
Training & Education
13.5.1.1.3.2.
Support Services
13.5.1.1.3.3.
Others
13.5.1.2. China Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.1.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.1.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.1.2.3. Others
13.5.1.3. China Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.5.1.3.1. Direct
13.5.1.3.2. Indirect
13.5.2. Japan
13.5.2.1. Japan Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
13.5.2.1.1. Equipment
13.5.2.1.1.1.
Sterilization & Monitoring
13.5.2.1.1.1.1. Steam Sterilizers
13.5.2.1.1.1.2. Low Temperature Sterilizers
13.5.2.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.2.1.1.1.4. Biological Indicators
13.5.2.1.1.1.5. Others
13.5.2.1.1.2.
Washer Disinfectors
13.5.2.1.1.3.
Endoscope Reprocessor Systems
13.5.2.1.1.4.
Others
13.5.2.1.2. Consumables
13.5.2.1.2.1.
Personal Protective Equipment
(PPE)
13.5.2.1.2.2.
Disinfectants
13.5.2.1.2.3.
Others
13.5.2.1.3. Services
13.5.2.1.3.1.
Training & Education
13.5.2.1.3.2.
Support Services
13.5.2.1.3.3.
Others
13.5.2.2. Japan Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.2.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.2.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.2.2.3. Others
13.5.2.3. Japan Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.5.2.3.1. Direct
13.5.2.3.2. Indirect
13.5.3. India
13.5.3.1. India Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
13.5.3.1.1. Equipment
13.5.3.1.1.1.
Sterilization & Monitoring
13.5.3.1.1.1.1. Steam Sterilizers
13.5.3.1.1.1.2. Low Temperature Sterilizers
13.5.3.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.3.1.1.1.4. Biological Indicators
13.5.3.1.1.1.5. Others
13.5.3.1.1.2.
Washer Disinfectors
13.5.3.1.1.3.
Endoscope Reprocessor Systems
13.5.3.1.1.4.
Others
13.5.3.1.2. Consumables
13.5.3.1.2.1.
Personal Protective Equipment
(PPE)
13.5.3.1.2.2.
Disinfectants
13.5.3.1.2.3.
Others
13.5.3.1.3. Services
13.5.3.1.3.1.
Training & Education
13.5.3.1.3.2.
Support Services
13.5.3.1.3.3.
Others
13.5.3.2. India Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.3.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.3.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.3.2.3. Others
13.5.3.3. India Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.5.3.3.1. Direct
13.5.3.3.2. Indirect
13.5.4. New
Zealand
13.5.4.1. New Zealand Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Offering
13.5.4.1.1. Equipment
13.5.4.1.1.1.
Sterilization & Monitoring
13.5.4.1.1.1.1. Steam Sterilizers
13.5.4.1.1.1.2. Low Temperature Sterilizers
13.5.4.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.4.1.1.1.4. Biological Indicators
13.5.4.1.1.1.5. Others
13.5.4.1.1.2.
Washer Disinfectors
13.5.4.1.1.3.
Endoscope Reprocessor Systems
13.5.4.1.1.4.
Others
13.5.4.1.2. Consumables
13.5.4.1.2.1.
Personal Protective Equipment
(PPE)
13.5.4.1.2.2.
Disinfectants
13.5.4.1.2.3.
Others
13.5.4.1.3. Services
13.5.4.1.3.1.
Training & Education
13.5.4.1.3.2.
Support Services
13.5.4.1.3.3.
Others
13.5.4.2. New Zealand Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.4.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.4.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.4.2.3. Others
13.5.4.3. New Zealand Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
13.5.4.3.1. Direct
13.5.4.3.2. Indirect
13.5.5. Australia
13.5.5.1. Australia Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Offering
13.5.5.1.1. Equipment
13.5.5.1.1.1.
Sterilization & Monitoring
13.5.5.1.1.1.1. Steam Sterilizers
13.5.5.1.1.1.2. Low Temperature Sterilizers
13.5.5.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.5.1.1.1.4. Biological Indicators
13.5.5.1.1.1.5. Others
13.5.5.1.1.2.
Washer Disinfectors
13.5.5.1.1.3.
Endoscope Reprocessor Systems
13.5.5.1.1.4.
Others
13.5.5.1.2. Consumables
13.5.5.1.2.1.
Personal Protective Equipment
(PPE)
13.5.5.1.2.2.
Disinfectants
13.5.5.1.2.3.
Others
13.5.5.1.3. Services
13.5.5.1.3.1.
Training & Education
13.5.5.1.3.2.
Support Services
13.5.5.1.3.3.
Others
13.5.5.2. Australia Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.5.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.5.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.5.2.3. Others
13.5.5.3. Australia Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
13.5.5.3.1. Direct
13.5.5.3.2. Indirect
13.5.6. South
Korea
13.5.6.1. South Korea Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Offering
13.5.6.1.1. Equipment
13.5.6.1.1.1.
Sterilization & Monitoring
13.5.6.1.1.1.1. Steam Sterilizers
13.5.6.1.1.1.2. Low Temperature Sterilizers
13.5.6.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.6.1.1.1.4. Biological Indicators
13.5.6.1.1.1.5. Others
13.5.6.1.1.2.
Washer Disinfectors
13.5.6.1.1.3.
Endoscope Reprocessor Systems
13.5.6.1.1.4.
Others
13.5.6.1.2. Consumables
13.5.6.1.2.1.
Personal Protective Equipment
(PPE)
13.5.6.1.2.2.
Disinfectants
13.5.6.1.2.3.
Others
13.5.6.1.3. Services
13.5.6.1.3.1.
Training & Education
13.5.6.1.3.2.
Support Services
13.5.6.1.3.3.
Others
13.5.6.2. South Korea Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.6.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.6.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.6.2.3. Others
13.5.6.3. South Korea Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
13.5.6.3.1. Direct
13.5.6.3.2. Indirect
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Offering
13.5.7.1.1. Equipment
13.5.7.1.1.1.
Sterilization & Monitoring
13.5.7.1.1.1.1. Steam Sterilizers
13.5.7.1.1.1.2. Low Temperature Sterilizers
13.5.7.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.7.1.1.1.4. Biological Indicators
13.5.7.1.1.1.5. Others
13.5.7.1.1.2.
Washer Disinfectors
13.5.7.1.1.3.
Endoscope Reprocessor Systems
13.5.7.1.1.4.
Others
13.5.7.1.2. Consumables
13.5.7.1.2.1.
Personal Protective Equipment
(PPE)
13.5.7.1.2.2.
Disinfectants
13.5.7.1.2.3.
Others
13.5.7.1.3. Services
13.5.7.1.3.1.
Training & Education
13.5.7.1.3.2.
Support Services
13.5.7.1.3.3.
Others
13.5.7.2. Southeast Asia Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.7.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.7.2.3. Others
13.5.7.3. Southeast Asia Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.7.3.1. Direct
13.5.7.3.2. Indirect
13.5.7.4. Southeast Asia Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.8.1.1. Equipment
13.5.8.1.1.1.
Sterilization & Monitoring
13.5.8.1.1.1.1. Steam Sterilizers
13.5.8.1.1.1.2. Low Temperature Sterilizers
13.5.8.1.1.1.3. Ethylene Oxide (EO) Sterilizers
13.5.8.1.1.1.4. Biological Indicators
13.5.8.1.1.1.5. Others
13.5.8.1.1.2.
Washer Disinfectors
13.5.8.1.1.3.
Endoscope Reprocessor Systems
13.5.8.1.1.4.
Others
13.5.8.1.2. Consumables
13.5.8.1.2.1.
Personal Protective Equipment
(PPE)
13.5.8.1.2.2.
Disinfectants
13.5.8.1.2.3.
Others
13.5.8.1.3. Services
13.5.8.1.3.1.
Training & Education
13.5.8.1.3.2.
Support Services
13.5.8.1.3.3.
Others
13.5.8.2. Rest of Asia Pacific Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.8.2.1. Hospitals & Intensive Care Units (ICUs)
13.5.8.2.2. Ambulatory Surgical Centers & Diagnostic Centers
13.5.8.2.3. Others
13.5.8.3. Rest of Asia Pacific Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.8.3.1. Direct
13.5.8.3.2. Indirect
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Offering
13.6.3. By End
Users
13.6.4. By
Distribution Channel
14. Middle East and Africa Hospital Acquired Infection Control
Market Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle
East and Africa Hospital Acquired Infection Control Market Revenue (US$ Mn)
14.2. Middle
East and Africa Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Offering
14.2.1. Equipment
14.2.1.1. Sterilization & Monitoring
14.2.1.1.1. Steam Sterilizers
14.2.1.1.2. Low Temperature Sterilizers
14.2.1.1.3. Ethylene Oxide (EO) Sterilizers
14.2.1.1.4. Biological Indicators
14.2.1.1.5. Others
14.2.1.2. Washer Disinfectors
14.2.1.3. Endoscope Reprocessor Systems
14.2.1.4. Others
14.2.2. Consumables
14.2.2.1. Personal Protective Equipment (PPE)
14.2.2.2. Disinfectants
14.2.2.3. Others
14.2.3. Services
14.2.3.1. Training & Education
14.2.3.2. Support Services
14.2.3.3. Others
14.3. Middle
East and Africa Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By End Users
14.3.1. Hospitals
& Intensive Care Units (ICUs)
14.3.2. Ambulatory
Surgical Centers & Diagnostic Centers
14.3.3. Others
14.4. Middle
East and Africa Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.4.1. Direct
14.4.2. Indirect
14.5. Middle
East and Africa Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Offering
14.5.1.1.1. Equipment
14.5.1.1.1.1.
Sterilization & Monitoring
14.5.1.1.1.1.1. Steam Sterilizers
14.5.1.1.1.1.2. Low Temperature Sterilizers
14.5.1.1.1.1.3. Ethylene Oxide (EO) Sterilizers
14.5.1.1.1.1.4. Biological Indicators
14.5.1.1.1.1.5. Others
14.5.1.1.1.2.
Washer Disinfectors
14.5.1.1.1.3.
Endoscope Reprocessor Systems
14.5.1.1.1.4.
Others
14.5.1.1.2. Consumables
14.5.1.1.2.1.
Personal Protective Equipment
(PPE)
14.5.1.1.2.2.
Disinfectants
14.5.1.1.2.3.
Others
14.5.1.1.3. Services
14.5.1.1.3.1.
Training & Education
14.5.1.1.3.2.
Support Services
14.5.1.1.3.3.
Others
14.5.1.2. Saudi Arabia Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.2.1. Hospitals & Intensive Care Units (ICUs)
14.5.1.2.2. Ambulatory Surgical Centers & Diagnostic Centers
14.5.1.2.3. Others
14.5.1.3. Saudi Arabia Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
14.5.1.3.1. Direct
14.5.1.3.2. Indirect
14.5.2. UAE
14.5.2.1. UAE Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
14.5.2.1.1. Equipment
14.5.2.1.1.1.
Sterilization & Monitoring
14.5.2.1.1.1.1. Steam Sterilizers
14.5.2.1.1.1.2. Low Temperature Sterilizers
14.5.2.1.1.1.3. Ethylene Oxide (EO) Sterilizers
14.5.2.1.1.1.4. Biological Indicators
14.5.2.1.1.1.5. Others
14.5.2.1.1.2.
Washer Disinfectors
14.5.2.1.1.3.
Endoscope Reprocessor Systems
14.5.2.1.1.4.
Others
14.5.2.1.2. Consumables
14.5.2.1.2.1.
Personal Protective Equipment
(PPE)
14.5.2.1.2.2.
Disinfectants
14.5.2.1.2.3.
Others
14.5.2.1.3. Services
14.5.2.1.3.1.
Training & Education
14.5.2.1.3.2.
Support Services
14.5.2.1.3.3.
Others
14.5.2.2. UAE Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.2.2.1. Hospitals & Intensive Care Units (ICUs)
14.5.2.2.2. Ambulatory Surgical Centers & Diagnostic Centers
14.5.2.2.3. Others
14.5.2.3. UAE Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.5.2.3.1. Direct
14.5.2.3.2. Indirect
14.5.3. Egypt
14.5.3.1. Egypt Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
14.5.3.1.1. Equipment
14.5.3.1.1.1.
Sterilization & Monitoring
14.5.3.1.1.1.1. Steam Sterilizers
14.5.3.1.1.1.2. Low Temperature Sterilizers
14.5.3.1.1.1.3. Ethylene Oxide (EO) Sterilizers
14.5.3.1.1.1.4. Biological Indicators
14.5.3.1.1.1.5. Others
14.5.3.1.1.2.
Washer Disinfectors
14.5.3.1.1.3.
Endoscope Reprocessor Systems
14.5.3.1.1.4.
Others
14.5.3.1.2. Consumables
14.5.3.1.2.1.
Personal Protective Equipment
(PPE)
14.5.3.1.2.2.
Disinfectants
14.5.3.1.2.3.
Others
14.5.3.1.3. Services
14.5.3.1.3.1.
Training & Education
14.5.3.1.3.2.
Support Services
14.5.3.1.3.3.
Others
14.5.3.2. Egypt Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.3.2.1. Hospitals & Intensive Care Units (ICUs)
14.5.3.2.2. Ambulatory Surgical Centers & Diagnostic Centers
14.5.3.2.3. Others
14.5.3.3. Egypt Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.5.3.3.1. Direct
14.5.3.3.2. Indirect
14.5.4. Kuwait
14.5.4.1. Kuwait Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
14.5.4.1.1. Equipment
14.5.4.1.1.1.
Sterilization & Monitoring
14.5.4.1.1.1.1. Steam Sterilizers
14.5.4.1.1.1.2. Low Temperature Sterilizers
14.5.4.1.1.1.3. Ethylene Oxide (EO) Sterilizers
14.5.4.1.1.1.4. Biological Indicators
14.5.4.1.1.1.5. Others
14.5.4.1.1.2.
Washer Disinfectors
14.5.4.1.1.3.
Endoscope Reprocessor Systems
14.5.4.1.1.4.
Others
14.5.4.1.2. Consumables
14.5.4.1.2.1.
Personal Protective Equipment
(PPE)
14.5.4.1.2.2.
Disinfectants
14.5.4.1.2.3.
Others
14.5.4.1.3. Services
14.5.4.1.3.1.
Training & Education
14.5.4.1.3.2.
Support Services
14.5.4.1.3.3.
Others
14.5.4.2. Kuwait Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.4.2.1. Hospitals & Intensive Care Units (ICUs)
14.5.4.2.2. Ambulatory Surgical Centers & Diagnostic Centers
14.5.4.2.3. Others
14.5.4.3. Kuwait Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.5.4.3.1. Direct
14.5.4.3.2. Indirect
14.5.5. South
Africa
14.5.5.1. South Africa Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By Offering
14.5.5.1.1. Equipment
14.5.5.1.1.1.
Sterilization & Monitoring
14.5.5.1.1.1.1. Steam Sterilizers
14.5.5.1.1.1.2. Low Temperature Sterilizers
14.5.5.1.1.1.3. Ethylene Oxide (EO) Sterilizers
14.5.5.1.1.1.4. Biological Indicators
14.5.5.1.1.1.5. Others
14.5.5.1.1.2.
Washer Disinfectors
14.5.5.1.1.3.
Endoscope Reprocessor Systems
14.5.5.1.1.4.
Others
14.5.5.1.2. Consumables
14.5.5.1.2.1.
Personal Protective Equipment
(PPE)
14.5.5.1.2.2.
Disinfectants
14.5.5.1.2.3.
Others
14.5.5.1.3. Services
14.5.5.1.3.1.
Training & Education
14.5.5.1.3.2.
Support Services
14.5.5.1.3.3.
Others
14.5.5.2. South Africa Hospital Acquired Infection Control Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.2.1. Hospitals & Intensive Care Units (ICUs)
14.5.5.2.2. Ambulatory Surgical Centers & Diagnostic Centers
14.5.5.2.3. Others
14.5.5.3. South Africa Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
14.5.5.3.1. Direct
14.5.5.3.2. Indirect
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Hospital Acquired Infection
Control Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.6.1.1. Equipment
14.5.6.1.1.1.
Sterilization & Monitoring
14.5.6.1.1.1.1. Steam Sterilizers
14.5.6.1.1.1.2. Low Temperature Sterilizers
14.5.6.1.1.1.3. Ethylene Oxide (EO) Sterilizers
14.5.6.1.1.1.4. Biological Indicators
14.5.6.1.1.1.5. Others
14.5.6.1.1.2.
Washer Disinfectors
14.5.6.1.1.3.
Endoscope Reprocessor Systems
14.5.6.1.1.4.
Others
14.5.6.1.2. Consumables
14.5.6.1.2.1.
Personal Protective Equipment
(PPE)
14.5.6.1.2.2.
Disinfectants
14.5.6.1.2.3.
Others
14.5.6.1.3. Services
14.5.6.1.3.1.
Training & Education
14.5.6.1.3.2.
Support Services
14.5.6.1.3.3.
Others
14.5.6.2. Rest of Middle East & Africa Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.6.2.1. Hospitals & Intensive Care Units (ICUs)
14.5.6.2.2. Ambulatory Surgical Centers & Diagnostic Centers
14.5.6.2.3. Others
14.5.6.3. Rest of Middle East & Africa Hospital Acquired Infection
Control Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.6.3.1. Direct
14.5.6.3.2. Indirect
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Offering
14.6.3. By End
Users
14.6.4. By
Distribution Channel
15. Latin America Hospital Acquired Infection Control Market
Analysis and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin
America Hospital Acquired Infection Control Market Revenue (US$ Mn)
15.2. Latin
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Offering
15.2.1. Equipment
15.2.1.1. Sterilization & Monitoring
15.2.1.1.1. Steam Sterilizers
15.2.1.1.2. Low Temperature Sterilizers
15.2.1.1.3. Ethylene Oxide (EO) Sterilizers
15.2.1.1.4. Biological Indicators
15.2.1.1.5. Others
15.2.1.2. Washer Disinfectors
15.2.1.3. Endoscope Reprocessor Systems
15.2.1.4. Others
15.2.2. Consumables
15.2.2.1. Personal Protective Equipment (PPE)
15.2.2.2. Disinfectants
15.2.2.3. Others
15.2.3. Services
15.2.3.1. Training & Education
15.2.3.2. Support Services
15.2.3.3. Others
15.3. Latin
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By End Users
15.3.1. Hospitals
& Intensive Care Units (ICUs)
15.3.2. Ambulatory
Surgical Centers & Diagnostic Centers
15.3.3. Others
15.4. Latin
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.4.1. Direct
15.4.2. Indirect
15.5. Latin
America Hospital Acquired Infection Control Market Revenue (US$ Mn) and
Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Offering
15.5.1.1.1. Equipment
15.5.1.1.1.1.
Sterilization & Monitoring
15.5.1.1.1.1.1. Steam Sterilizers
15.5.1.1.1.1.2. Low Temperature Sterilizers
15.5.1.1.1.1.3. Ethylene Oxide (EO) Sterilizers
15.5.1.1.1.1.4. Biological Indicators
15.5.1.1.1.1.5. Others
15.5.1.1.1.2.
Washer Disinfectors
15.5.1.1.1.3.
Endoscope Reprocessor Systems
15.5.1.1.1.4.
Others
15.5.1.1.2. Consumables
15.5.1.1.2.1.
Personal Protective Equipment
(PPE)
15.5.1.1.2.2.
Disinfectants
15.5.1.1.2.3.
Others
15.5.1.1.3. Services
15.5.1.1.3.1.
Training & Education
15.5.1.1.3.2.
Support Services
15.5.1.1.3.3.
Others
15.5.1.2. Brazil Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By End Users
15.5.1.2.1. Hospitals & Intensive Care Units (ICUs)
15.5.1.2.2. Ambulatory Surgical Centers & Diagnostic Centers
15.5.1.2.3. Others
15.5.1.3. Brazil Hospital Acquired Infection Control Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
15.5.1.3.1. Direct
15.5.1.3.2. Indirect
15.5.2. Argentina
15.5.2.1. Argentina Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Offering
15.5.2.1.1. Equipment
15.5.2.1.1.1.
Sterilization & Monitoring
15.5.2.1.1.1.1. Steam Sterilizers
15.5.2.1.1.1.2. Low Temperature Sterilizers
15.5.2.1.1.1.3. Ethylene Oxide (EO) Sterilizers
15.5.2.1.1.1.4. Biological Indicators
15.5.2.1.1.1.5. Others
15.5.2.1.1.2.
Washer Disinfectors
15.5.2.1.1.3.
Endoscope Reprocessor Systems
15.5.2.1.1.4.
Others
15.5.2.1.2. Consumables
15.5.2.1.2.1.
Personal Protective Equipment
(PPE)
15.5.2.1.2.2.
Disinfectants
15.5.2.1.2.3.
Others
15.5.2.1.3. Services
15.5.2.1.3.1.
Training & Education
15.5.2.1.3.2.
Support Services
15.5.2.1.3.3.
Others
15.5.2.2. Argentina Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By End Users
15.5.2.2.1. Hospitals & Intensive Care Units (ICUs)
15.5.2.2.2. Ambulatory Surgical Centers & Diagnostic Centers
15.5.2.2.3. Others
15.5.2.3. Argentina Hospital Acquired Infection Control Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
15.5.2.3.1. Direct
15.5.2.3.2. Indirect
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.3.1.1. Equipment
15.5.3.1.1.1.
Sterilization & Monitoring
15.5.3.1.1.1.1. Steam Sterilizers
15.5.3.1.1.1.2. Low Temperature Sterilizers
15.5.3.1.1.1.3. Ethylene Oxide (EO) Sterilizers
15.5.3.1.1.1.4. Biological Indicators
15.5.3.1.1.1.5. Others
15.5.3.1.1.2.
Washer Disinfectors
15.5.3.1.1.3.
Endoscope Reprocessor Systems
15.5.3.1.1.4.
Others
15.5.3.1.2. Consumables
15.5.3.1.2.1.
Personal Protective Equipment
(PPE)
15.5.3.1.2.2.
Disinfectants
15.5.3.1.2.3.
Others
15.5.3.1.3. Services
15.5.3.1.3.1.
Training & Education
15.5.3.1.3.2.
Support Services
15.5.3.1.3.3.
Others
15.5.3.2. Rest of Latin America Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.3.2.1. Hospitals & Intensive Care Units (ICUs)
15.5.3.2.2. Ambulatory Surgical Centers & Diagnostic Centers
15.5.3.2.3. Others
15.5.3.3. Rest of Latin America Hospital Acquired Infection Control
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.5.3.3.1. Direct
15.5.3.3.2. Indirect
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Offering
15.6.3. By End
Users
15.6.4. By
Distribution Channel
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2020
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. 3M
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. ASP
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. BELIMED,
INC.
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT Analysis
17.3.7. Business
Strategies
17.4. ContecClean
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Drägerwerk
AG & Co. KGaA
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Ecolab
Inc.
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Getinge
AB
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. Keystone
Healthcare
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. MATACHANA
GROUP
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. MELAG
Medizintechnik GmbH & Co. KG
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Sterigenics
U.S., LLC
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. STERIS
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Other
Market Participants
18. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.